Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Hwail Pharm Co., Ltd. (061250)
Market Closed
11 Aug, 06:30
KRX SM
All
(1)
KR
(1)
KRX SM
Primary
₩
8,840.
00
-30
-0.3382%
₩
67.51B
Market Cap
-
P/E Ratio
1,666.67%
Div Yield
2,072
Volume
-
Eps
₩
8,870
Previous Close
Watching
Watch
Add Transaction
Day Range
8,700
8,990
Year Range
7,090
13,800
Want to track
061250
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Splits
Statistics
Historical Data
Hwail Pharm Co., Ltd. (061250) Statistics
Valuation metrics
Market Cap
67.51B
Enterprise value
36.53B
Trailing P/E (ttm)
-267.33
Forward P/E
-
PEG ratio
1.43
Price/Sales (ttm)
0.67
Price/Book (mrq)
0.32
Enterprise Value/Revenue
0.34
Enterprise Value/EBITDA
7.03
Overview
Shares outstanding
8.42M
Float
2.23M
Shares short
-
% Held by insiders
0.45%
% Held by institutions
0%
Average volume (10 days)
27.79K
Average volume (90 days)
26.99K
Price summary
52-Week low
7,090
52-Week high
13,800
Beta
0.21
50-Day moving average
9,643.4
200-Day moving average
10,982.6
Dividends and splits
Forward annual dividend rate
1,666.67
Forward annual dividend yield
0.2078%
Trailing annual dividend rate
416.67
Trailing annual dividend yield
0.052%
5-Year annual dividend yield
1.93%
Payout ratio
-
Dividend Date
5 Jan 2021
Ex-Dividend Date
29 Dec 2020
Last split factor
0.1:1
Last split Date
7 Apr 2026
Financials
Fiscal year
Fiscal year ends
31 Dec 2016
Most recent quarter (mrq)
31 Mar 2026
Profitability
Profit margin
0.02%
Operating margin
0.06%
Operational effectiveness
Return on assets
0.01%
Return on equity
0.02%
Income Statement
Revenue (ttm)
107.87B
Revenue per share (ttm)
26,591.18
Quarterly revenue growth (yoy)
-0.12%
Gross profit (ttm)
14.09B
EBITDA
623.78M
Net income to common (ttm)
1.92B
Diluted EPS (ttm)
-30
Quarterly earnings growth (yoy)
-0.83%
Balance Sheet
Total cash (mrq)
11.83B
Total cash per share (mrq)
2,916.25
Total debt (mrq)
15.83B
Total Debt/Equity (mrq)
16.15
Current ratio (mrq)
3.67%
Book value per share (mrq)
25,217.44
Cash Flow
Cash flow statement
11.2B
Levered free cash flow (LFCF)
9.91B